1. Market Research
  2. > Cancer Industry

Prostate Cancer Industry, July 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Biopsy, Hormone, Cancer Diagnostic, Magnetic Resonance Imaging, Genetic, Healthcare, Vaccine, Biomarker, Oncology, Urology, Blood Disease, Lung Cancer, Medical Robotics, Nuclear Imaging Equipment, Pharmaceutical, Transdermal Delivery.


 
1-10 of 84 reports for Prostate Cancer

Purchase Reports From Reputable Market Research Publishers

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016" provides ...

Global Prostate Cancer Partnering 2010 to 2016

Global Prostate Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • July 2016
  • by Currentpartnering

Provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies . The Global Therapy Partnering Terms and Agreements since ...

US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

  • $ 4 995
  • Industry report
  • July 2016
  • by iData Research, Inc.

Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one ...

Prostate Cancer - Pipeline Review, H1 2016

Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape. The report ...

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ...

Treatment of Prostate Cancer - Patent Overview in the years 2011 - 2016

Treatment of Prostate Cancer - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around the urethra. Prostate cance ...

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

Global circulating tumor cells market is expected to reach USD 2.28 billion by 2020. Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cate ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, ...

Global Prostate Cancer Therapeutics Industry

Global Prostate Cancer Therapeutics Industry

  • $ 4 500
  • Industry report
  • May 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report provides separate comprehensive analytics ...

The Prostate Cancer Market 2016-2026: Increasing Incidence and Promising New Therapies to Drive Market Growth

The Prostate Cancer Market 2016-2026: Increasing Incidence and Promising New Therapies to Drive Market Growth

  • $ 2 651
  • Industry report
  • April 2016
  • by Visiongain

Report Details What can be expected from the prostate cancer market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, ...

About 5 200 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Prostate Cancer Statistics and Obesity Statistics in the US

  • December 2014
    174 pages
  • Prostate Cancer  

    Obesity  

    Endocrine Disea...  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.